Authors:
Sherman, DG
Bes, A
Easton, JD
Hacke, W
Kaste, M
Polmar, SH
Zivin, JA
Fieschi, C
Miller, P
Schoenfeld, D
Street, J
Albers, G
Atkinson, R
Biller, J
Bruno, A
Carpenter, D
Clark, W
DeGraba, T
Driscoll, P
Ellis, J
Greenlee, R
Hess, D
Horowitz, DR
Davenport, J
Hsu, C
Starkman, S
Madden, K
Pettigrew, C
Rosenbaum, D
Schim, J
Tietjen, G
Mansbach, H
Edwards, K
Webb, R
Crisostomo, E
Wilterdink, J
Rothrock, J
Zweifler, R
Dexter, J
Horowitz, S
Futrell, N
Alter, M
Schneider, D
Ferbert, A
Hacke, W
Prange, H
Wiersbitzky, M
Buttner, T
Schwartz, A
Busse, O
Klingelhofer, J
Kaste, M
Erila, T
Sivenius, J
Sotaniemi, K
Liukkonen, J
Hedman, C
Muuronen, A
Rissanen, A
Bes, A
Feve, JR
Mahagne, MH
Rancurel, G
Trouillas, P
Weber, M
Thomassen, L
Johnsen, HJ
Kjallman, L
Petersson, J
Ferrari, G
Lagi, A
Mamoli, A
Re, G
Citation: Dg. Sherman et al., Use of anti-ICAM-1 therapy in ischemic stroke - Results of the Enlimomab Acute Stroke Trial, NEUROLOGY, 57(8), 2001, pp. 1428-1434